Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference4 articles.
1. Finerenone: a new era for mineralocorticoid receptor antagonism and cardiorenal protection;Parfianowicz;Curr Probl Cardiol,2022
2. hyperkalemia risk with finerenone: results from the FIDELIO-DKD trial;Agarwal;J Am Soc Nephrol,2022
3. Novel therapies in diabetic kidney disease and risk of hyperkalemia: a review of the evidence from clinical trials;Albakr;Am J Kidney Dis,2023
4. Potassium management with finerenone: practical aspects;Wanner;Endocrinol Diabetes Metab,2022